Fundraising FoxH.I.G. BioHealth Partners
Growth equityGrowth · 6 people tracked
Find your way into H.I.G. BioHealth Partners
Sign up to find every way you can get introduced to H.I.G. BioHealth Partners
- Your email: who you already know at H.I.G. BioHealth Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the H.I.G. BioHealth Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The firm invests in growth-stage healthcare businesses with the aim of improving patient outcomes while reducing overall healthcare costs. Its investment team brings experience across pharmaceuticals, biotech, medical devices, diagnostics, and related services. Leveraging the broader H.I.G. platform of over 500 investment professionals across 18 global offices, the fund provides operational value-creation support to mid-sized companies, partnering with founders and management teams to drive operational improvements and build market-leading positions.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website
What they invest in
from 7 of 7 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×4Consumer ×2Digital Health ×2Circular Economy ×1
HQs:United States×3Switzerland×1Netherlands×1
Investments · 7 tracked
founders shown can be your intro pathBy year:2025 · 12019 · 12018 · 24 dated
Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.
BiotechConsumerHealthtechZug, CH
Co-investorsAndera PartnersF-Prime CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersBRV Capital ManagementLife Sciences Partners
Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.
BiotechDigital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)inRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)
BoardAlex Zisson(Director)
Co-investorsAccelmed PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersHealth Catalyst CapitalHikma VenturesRevelation Partners+5 more
BiotechHealthtechWayne, US
Robert Giasolli(Executive Officer)Bruce J. Shook(Executive Officer, Director)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Michael Longo(Executive Officer)
Co-investors415 CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersRunway Growth CapitalNew Enterprise Associates (NEA)Vensana Capital
Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.
Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL
Co-investorsExcel Venture ManagementNew Enterprise Associates (NEA)Sanderling VenturesH.I.G. Capital
On Target Laboratories is a company of scientists and researchers focused on cancer surgery, developing products to support surgical oncology.
BiotechHealthtechMedical Devices
Bill Peters(President, Chief Executive Officer, and Board Member)inRod MacLeod(Chief Financial Officer)inTommy Lee(Senior Vice President of Clinical Operations)inCatherine Brisson(Vice President of Regulatory Affairs and Quality)Anne Fornicola(Vice President of Chemistry, Manufacturing and Controls)inScott Huennekens(Executive Chairperson)in
Co-investors3B Future Health FundCerity Partners VenturesElevate VenturesH.I.G. CapitalH.I.G. HealthBridge Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesClick Therapeutics · finsmes.com · Apr 9, 2026
Frequently asked questions
- How many investments has H.I.G. BioHealth Partners made?
- H.I.G. BioHealth Partners has 7 tracked investments, including 1 dated in the last 24 months.
- What stage does H.I.G. BioHealth Partners invest at?
- H.I.G. BioHealth Partners invests at the Growth stage.
- What sectors does H.I.G. BioHealth Partners focus on?
- H.I.G. BioHealth Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.